Request Free Sample ×
South America Microneedling Market -Forecast to 2035 Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

South America Microneedling Market

ID: MRFR/MED/48357-HCR
200 Pages
Nidhi Mandole
Last Updated: April 06, 2026

South America Microneedling Market Research Report By Procedure (RF Microneedling, Traditional Microneedling, PRP Microneedling), By Product (Derma-Stamp, Dermapen, Dermarollers, RF Microneedling Devices, Others), By Needle Material (Silicon, Metal, Glass, Others), By Application (Skin Rejuvenation, Acne Scars, Traumatic & Surgical Scars, Others), By End-User (Hospitals, Dermatology Clinics, Homecare Settings, Others) and By Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

South America Microneedling Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Pharmaceutical, BY Procedure (USD Million)
  49.     4.1.1 RF Microneedling
  50.     4.1.2 Traditional Microneedling
  51.     4.1.3 PRP Microneedling
  52.   4.2 Pharmaceutical, BY Product (USD Million)
  53.     4.2.1 Derma-Stamp
  54.     4.2.2 Dermapen
  55.     4.2.3 Dermarollers
  56.     4.2.4 RF Microneedling Devices
  57.     4.2.5 Others
  58.   4.3 Pharmaceutical, BY Needle Material (USD Million)
  59.     4.3.1 Silicon
  60.     4.3.2 Metal
  61.     4.3.3 Glass
  62.     4.3.4 Others
  63.   4.4 Pharmaceutical, BY Application (USD Million)
  64.     4.4.1 Skin Rejuvenation
  65.     4.4.2 Acne Scars
  66.     4.4.3 Traumatic & Surgical Scars
  67.     4.4.4 Others
  68.   4.5 Pharmaceutical, BY End-User (USD Million)
  69.     4.5.1 Hospitals
  70.     4.5.2 Dermatology Clinics
  71.     4.5.3 Homecare Settings
  72.     4.5.4 Others
  73. 5 SECTION V: COMPETITIVE ANALYSIS
  74.   5.1 Competitive Landscape
  75.     5.1.1 Overview
  76.     5.1.2 Competitive Analysis
  77.     5.1.3 Market share Analysis
  78.     5.1.4 Major Growth Strategy in the Pharmaceutical
  79.     5.1.5 Competitive Benchmarking
  80.     5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  81.     5.1.7 Key developments and growth strategies
  82.       5.1.7.1 New Product Launch/Service Deployment
  83.       5.1.7.2 Merger & Acquisitions
  84.       5.1.7.3 Joint Ventures
  85.     5.1.8 Major Players Financial Matrix
  86.       5.1.8.1 Sales and Operating Income
  87.       5.1.8.2 Major Players R&D Expenditure. 2023
  88.   5.2 Company Profiles
  89.     5.2.1 Revance Therapeutics (US)
  90.       5.2.1.1 Financial Overview
  91.       5.2.1.2 Products Offered
  92.       5.2.1.3 Key Developments
  93.       5.2.1.4 SWOT Analysis
  94.       5.2.1.5 Key Strategies
  95.     5.2.2 Hyaluronic Acid (US)
  96.       5.2.2.1 Financial Overview
  97.       5.2.2.2 Products Offered
  98.       5.2.2.3 Key Developments
  99.       5.2.2.4 SWOT Analysis
  100.       5.2.2.5 Key Strategies
  101.     5.2.3 Merz Pharmaceuticals (DE)
  102.       5.2.3.1 Financial Overview
  103.       5.2.3.2 Products Offered
  104.       5.2.3.3 Key Developments
  105.       5.2.3.4 SWOT Analysis
  106.       5.2.3.5 Key Strategies
  107.     5.2.4 Cynosure (US)
  108.       5.2.4.1 Financial Overview
  109.       5.2.4.2 Products Offered
  110.       5.2.4.3 Key Developments
  111.       5.2.4.4 SWOT Analysis
  112.       5.2.4.5 Key Strategies
  113.     5.2.5 Dermaroller (DE)
  114.       5.2.5.1 Financial Overview
  115.       5.2.5.2 Products Offered
  116.       5.2.5.3 Key Developments
  117.       5.2.5.4 SWOT Analysis
  118.       5.2.5.5 Key Strategies
  119.     5.2.6 SkinPen (US)
  120.       5.2.6.1 Financial Overview
  121.       5.2.6.2 Products Offered
  122.       5.2.6.3 Key Developments
  123.       5.2.6.4 SWOT Analysis
  124.       5.2.6.5 Key Strategies
  125.     5.2.7 Bellus Medical (US)
  126.       5.2.7.1 Financial Overview
  127.       5.2.7.2 Products Offered
  128.       5.2.7.3 Key Developments
  129.       5.2.7.4 SWOT Analysis
  130.       5.2.7.5 Key Strategies
  131.     5.2.8 Aesthetic Solutions (US)
  132.       5.2.8.1 Financial Overview
  133.       5.2.8.2 Products Offered
  134.       5.2.8.3 Key Developments
  135.       5.2.8.4 SWOT Analysis
  136.       5.2.8.5 Key Strategies
  137.   5.3 Appendix
  138.     5.3.1 References
  139.     5.3.2 Related Reports
  140. 6 LIST OF FIGURES
  141.   6.1 MARKET SYNOPSIS
  142.   6.2 SOUTH AMERICA MARKET ANALYSIS BY PROCEDURE
  143.   6.3 SOUTH AMERICA MARKET ANALYSIS BY PRODUCT
  144.   6.4 SOUTH AMERICA MARKET ANALYSIS BY NEEDLE MATERIAL
  145.   6.5 SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
  146.   6.6 SOUTH AMERICA MARKET ANALYSIS BY END-USER
  147.   6.7 KEY BUYING CRITERIA OF PHARMACEUTICAL
  148.   6.8 RESEARCH PROCESS OF MRFR
  149.   6.9 DRO ANALYSIS OF PHARMACEUTICAL
  150.   6.10 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
  151.   6.11 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
  152.   6.12 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
  153.   6.13 PHARMACEUTICAL, BY PROCEDURE, 2024 (% SHARE)
  154.   6.14 PHARMACEUTICAL, BY PROCEDURE, 2024 TO 2035 (USD Million)
  155.   6.15 PHARMACEUTICAL, BY PRODUCT, 2024 (% SHARE)
  156.   6.16 PHARMACEUTICAL, BY PRODUCT, 2024 TO 2035 (USD Million)
  157.   6.17 PHARMACEUTICAL, BY NEEDLE MATERIAL, 2024 (% SHARE)
  158.   6.18 PHARMACEUTICAL, BY NEEDLE MATERIAL, 2024 TO 2035 (USD Million)
  159.   6.19 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
  160.   6.20 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
  161.   6.21 PHARMACEUTICAL, BY END-USER, 2024 (% SHARE)
  162.   6.22 PHARMACEUTICAL, BY END-USER, 2024 TO 2035 (USD Million)
  163.   6.23 BENCHMARKING OF MAJOR COMPETITORS
  164. 7 LIST OF TABLES
  165.   7.1 LIST OF ASSUMPTIONS
  166.     7.1.1
  167.   7.2 South America MARKET SIZE ESTIMATES; FORECAST
  168.     7.2.1 BY PROCEDURE, 2025-2035 (USD Million)
  169.     7.2.2 BY PRODUCT, 2025-2035 (USD Million)
  170.     7.2.3 BY NEEDLE MATERIAL, 2025-2035 (USD Million)
  171.     7.2.4 BY APPLICATION, 2025-2035 (USD Million)
  172.     7.2.5 BY END-USER, 2025-2035 (USD Million)
  173.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  174.     7.3.1
  175.   7.4 ACQUISITION/PARTNERSHIP
  176.     7.4.1

South America Pharmaceutical Market Segmentation

Pharmaceutical By Procedure (USD Million, 2025-2035)

  • RF Microneedling
  • Traditional Microneedling
  • PRP Microneedling

Pharmaceutical By Product (USD Million, 2025-2035)

  • Derma-Stamp
  • Dermapen
  • Dermarollers
  • RF Microneedling Devices
  • Others

Pharmaceutical By Needle Material (USD Million, 2025-2035)

  • Silicon
  • Metal
  • Glass
  • Others

Pharmaceutical By Application (USD Million, 2025-2035)

  • Skin Rejuvenation
  • Acne Scars
  • Traumatic & Surgical Scars
  • Others

Pharmaceutical By End-User (USD Million, 2025-2035)

  • Hospitals
  • Dermatology Clinics
  • Homecare Settings
  • Others

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓